US Patent No: 6,632,830

Number of patents in Portfolio can not be more than 2000

ACE-2 inhibiting compounds and methods of use thereof

Stats

ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

ACE-2 inhibiting compounds are disclosed. These compounds include compounds of formula (IV): ##STR1## wherein the variables are as described in the specification. Pharmaceutical compositions containing the compounds are also discussed. The pharmaceutical compositions may contain an effective amount of a compound of the invention to treat ACE-2 associated disorders such as a blood pressure related disease or disorder, cell proliferation disorder, kidney disorder, kinetensin associated disorder, inflammation associated disorder, or an allergic disorder.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
MILLENNIUM PHARMACEUTICALS, INC.CAMBRIDGE, MA855

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Acton, Susan L Lexington, MA 19 47
Brown, James A Framingham, MA 12 136
Dales, Natalie A Arlington, MA 9 19
Gould, Alexandra E Cambridge, MA 16 23
Guan, Bing Chestnut Hill, MA 19 29
Ocain, Timothy D Framingham, MA 18 214

Cited Art

Patent Info (Count) # Cites Year
 
BAXTER INTERNATIONAL INC. (1)
5,827,820 Aqueous peritoneal dialysis solution 33 1997
 
FUJI PHOTO FILM CO., LTD. (1)
5,338,649 Photographic processing composition and bleaching or bleach-fixing method 13 1993
 
MERCK & CO., INC. (1)
5,110,799 Antiherpetic agents 3 1989
 
MILLENNIUM PHARMACEUTICALS, INC. (1)
6,194,556 Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therfor 13 1997
 
NATIONAL RESEARCH DEVELOPMENT CORPORATION (1)
4,591,648 Histidine protection 16 1982
 
ONO PHARMACEUTICAL CO., LTD. (1)
6,201,021 Pentanoic acid derivatives 10 1996
 
The Dow Chemical Company (1)
5,481,018 Amino nitrile intermediate for the preparation of alanine diacetic acid 9 1995
 
Other [Check patent profile for assignment information] (1)
5,665,371 Medicines which contain derivatives of proline or hydroxyproline 4 1996

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
S.C. JOHNSON & SON, INC. (3)
7,407,922 Deodorizing compositions 1 2005
7,261,742 Method of deodorizing a textile 2 2006
7,407,515 Method of deodorizing a textile 0 2007
 
APEIRON BIOLOGICS AG (2)
7,794,707 ACE2 activation for treatment of heart, lung and kidney disease and hypertension 0 2003
8,211,426 ACE2 activation for treatment of heart, lung and kidney disease and hypertension 0 2010
 
MILLENNIUM PHARMACEUTICALS, INC. (1)
7,045,532 ACE-2 modulating compounds and methods of use thereof 2 2001
 
ORE PHARMACEUTICALS, INC. (1)
7,842,709 Method for treating inflammatory diseases of the digestive tract 0 2007

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 14, 2015
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00